These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 34968416)

  • 1. Recruitment of highly cytotoxic CD8
    Wagner KI; Mateyka LM; Jarosch S; Grass V; Weber S; Schober K; Hammel M; Burrell T; Kalali B; Poppert H; Beyer H; Schambeck S; Holdenrieder S; Strötges-Achatz A; Haselmann V; Neumaier M; Erber J; Priller A; Yazici S; Roggendorf H; Odendahl M; Tonn T; Dick A; Witter K; Mijočević H; Protzer U; Knolle PA; Pichlmair A; Crowell CS; Gerhard M; D'Ippolito E; Busch DH
    Cell Rep; 2022 Jan; 38(2):110214. PubMed ID: 34968416
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A
    Nesterenko PA; McLaughlin J; Tsai BL; Burton Sojo G; Cheng D; Zhao D; Mao Z; Bangayan NJ; Obusan MB; Su Y; Ng RH; Chour W; Xie J; Li YR; Lee D; Noguchi M; Carmona C; Phillips JW; Kim JT; Yang L; Heath JR; Boutros PC; Witte ON
    Cell Rep; 2021 Dec; 37(13):110167. PubMed ID: 34919800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2.
    Shimizu K; Iyoda T; Sanpei A; Nakazato H; Okada M; Ueda S; Kato-Murayama M; Murayama K; Shirouzu M; Harada N; Hidaka M; Fujii SI
    Commun Biol; 2021 Dec; 4(1):1365. PubMed ID: 34857854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural assessment of HLA-A2-restricted SARS-CoV-2 spike epitopes recognized by public and private T-cell receptors.
    Wu D; Kolesnikov A; Yin R; Guest JD; Gowthaman R; Shmelev A; Serdyuk Y; Dianov DV; Efimov GA; Pierce BG; Mariuzza RA
    Nat Commun; 2022 Jan; 13(1):19. PubMed ID: 35013235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Qiu C; Xiao C; Wang Z; Zhu G; Mao L; Chen X; Gao L; Deng J; Su J; Su H; Fang EF; Zhang ZJ; Zhang J; Xie C; Yuan J; Luo OJ; Huang LA; Wang P; Chen G
    Front Immunol; 2021; 12():764949. PubMed ID: 35116022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2-specific CD8
    Rowntree LC; Audsley J; Allen LF; McQuilten HA; Hagen RR; Chaurasia P; Petersen J; Littler DR; Tan HX; Murdiyarso L; Habel JR; Foo IJH; Zhang W; Ten Berge ERV; Ganesh H; Kaewpreedee P; Lee KWK; Cheng SMS; Kwok JSY; Jayasinghe D; Gras S; Juno JA; Wheatley AK; Kent SJ; Rossjohn J; Cheng AC; Kotsimbos TC; Trubiano JA; Holmes NE; Pang Chan KK; Hui DSC; Peiris M; Poon LLM; Lewin SR; Doherty PC; Thevarajan I; Valkenburg SA; Kedzierska K; Nguyen THO
    Proc Natl Acad Sci U S A; 2024 Sep; 121(39):e2411428121. PubMed ID: 39284068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-specific CD8
    Rowntree LC; Petersen J; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Wheatley AK; Kent SJ; Rossjohn J; Kedzierska K; Nguyen TH
    Immunol Cell Biol; 2021 Oct; 99(9):990-1000. PubMed ID: 34086357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunodominant T-cell epitopes from the SARS-CoV-2 spike antigen reveal robust pre-existing T-cell immunity in unexposed individuals.
    Mahajan S; Kode V; Bhojak K; Karunakaran C; Lee K; Manoharan M; Ramesh A; Hv S; Srivastava A; Sathian R; Khan T; Kumar P; Gupta R; Chakraborty P; Chaudhuri A
    Sci Rep; 2021 Jun; 11(1):13164. PubMed ID: 34162945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 specific memory T cell epitopes identified in COVID-19-recovered subjects.
    Zhao J; Wang L; Schank M; Dang X; Lu Z; Cao D; Khanal S; Nguyen LN; Nguyen LNT; Zhang J; Zhang Y; Adkins JL; Baird EM; Wu XY; Ning S; Gazzar ME; Moorman JP; Yao ZQ
    Virus Res; 2021 Oct; 304():198508. PubMed ID: 34329696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.
    Chaurasia P; Nguyen THO; Rowntree LC; Juno JA; Wheatley AK; Kent SJ; Kedzierska K; Rossjohn J; Petersen J
    J Biol Chem; 2021 Sep; 297(3):101065. PubMed ID: 34384783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Basis of a Dominant SARS-CoV-2 Spike-Derived Epitope Presented by HLA-A*02:01 Recognised by a Public TCR.
    Szeto C; Nguyen AT; Lobos CA; Chatzileontiadou DSM; Jayasinghe D; Grant EJ; Riboldi-Tunnicliffe A; Smith C; Gras S
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Epitopes Are Recognized by a Public and Diverse Repertoire of Human T Cell Receptors.
    Shomuradova AS; Vagida MS; Sheetikov SA; Zornikova KV; Kiryukhin D; Titov A; Peshkova IO; Khmelevskaya A; Dianov DV; Malasheva M; Shmelev A; Serdyuk Y; Bagaev DV; Pivnyuk A; Shcherbinin DS; Maleeva AV; Shakirova NT; Pilunov A; Malko DB; Khamaganova EG; Biderman B; Ivanov A; Shugay M; Efimov GA
    Immunity; 2020 Dec; 53(6):1245-1257.e5. PubMed ID: 33326767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insights into immune escape at killer T cell epitope by SARS-CoV-2 Spike Y453F variants.
    Deng S; Xu Z; Wang M; Hu J; Liu Z; Zhu F; Zheng P; Kombe Kombe AJ; Zhang H; Wu S; Jin T
    J Biol Chem; 2024 Aug; 300(8):107563. PubMed ID: 39002680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degenerate CD8 Epitopes Mapping to Structurally Constrained Regions of the Spike Protein: A T Cell-Based Way-Out From the SARS-CoV-2 Variants Storm.
    Boni C; Cavazzini D; Bolchi A; Rossi M; Vecchi A; Tiezzi C; Barili V; Fisicaro P; Ferrari C; Ottonello S
    Front Immunol; 2021; 12():730051. PubMed ID: 34566990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human CD4
    Verhagen J; van der Meijden ED; Lang V; Kremer AE; Völkl S; Mackensen A; Aigner M; Kremer AN
    Clin Exp Immunol; 2021 Sep; 205(3):363-378. PubMed ID: 34061349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.